MY103289A - New 5-(w-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes - Google Patents

New 5-(w-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes

Info

Publication number
MY103289A
MY103289A MYPI88000561A MYPI19880561A MY103289A MY 103289 A MY103289 A MY 103289A MY PI88000561 A MYPI88000561 A MY PI88000561A MY PI19880561 A MYPI19880561 A MY PI19880561A MY 103289 A MY103289 A MY 103289A
Authority
MY
Malaysia
Prior art keywords
tetrahydrothiophenes
tetrahydrofurans
new
ammonio
acyloxy methylene
Prior art date
Application number
MYPI88000561A
Other languages
English (en)
Inventor
Braquet Pierre
Godfroid Jean-Jacque
Heymans Francoise
Original Assignee
Soc De Conseils De Recherches S C R A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc De Conseils De Recherches S C R A S filed Critical Soc De Conseils De Recherches S C R A S
Publication of MY103289A publication Critical patent/MY103289A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI88000561A 1987-05-29 1988-05-26 New 5-(w-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes MY103289A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc

Publications (1)

Publication Number Publication Date
MY103289A true MY103289A (en) 1993-05-29

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI88000561A MY103289A (en) 1987-05-29 1988-05-26 New 5-(w-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes

Country Status (32)

Country Link
US (1) US5017588A (sv)
JP (1) JPH0631228B2 (sv)
KR (1) KR960005152B1 (sv)
AR (1) AR243885A1 (sv)
AT (1) AT395715B (sv)
AU (1) AU610789B2 (sv)
BE (1) BE1002146A3 (sv)
CA (1) CA1317959C (sv)
CH (1) CH674985A5 (sv)
DE (1) DE3818106A1 (sv)
DK (1) DK167532B1 (sv)
ES (1) ES2009924A6 (sv)
FI (1) FI89353C (sv)
FR (2) FR2615735B1 (sv)
GB (2) GB8712693D0 (sv)
GR (1) GR1000147B (sv)
HK (1) HK101790A (sv)
IE (1) IE61341B1 (sv)
IN (1) IN168799B (sv)
IT (1) IT1219698B (sv)
LU (1) LU87229A1 (sv)
MA (1) MA21289A1 (sv)
MY (1) MY103289A (sv)
NL (1) NL192203C (sv)
NO (1) NO170086C (sv)
NZ (1) NZ224775A (sv)
OA (1) OA08878A (sv)
PT (1) PT87585B (sv)
SE (1) SE466449B (sv)
SG (1) SG93790G (sv)
TN (1) TNSN88049A1 (sv)
ZA (1) ZA883731B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
SG93790G (en) 1991-01-18
JPS649988A (en) 1989-01-13
GR1000147B (el) 1991-09-27
FI89353B (fi) 1993-06-15
AU610789B2 (en) 1991-05-23
JPH0631228B2 (ja) 1994-04-27
GB2205100B (en) 1990-08-15
GB2205100A (en) 1988-11-30
NO882335D0 (no) 1988-05-27
CH674985A5 (sv) 1990-08-15
SE8801964D0 (sv) 1988-05-26
IN168799B (sv) 1991-06-08
FI89353C (sv) 1993-09-27
GB8712693D0 (en) 1987-07-01
NL192203C (nl) 1997-03-04
AU1672288A (en) 1988-12-01
FR2615854A1 (fr) 1988-12-02
NL192203B (nl) 1996-11-01
FI882475A0 (fi) 1988-05-26
NZ224775A (en) 1990-01-29
NO882335L (no) 1988-11-30
PT87585B (pt) 1992-09-30
NO170086C (no) 1992-09-09
PT87585A (pt) 1989-05-31
IT8820773A0 (it) 1988-05-27
GR880100342A (en) 1989-02-23
GB8812488D0 (en) 1988-06-29
DK291088D0 (da) 1988-05-27
DE3818106A1 (de) 1988-12-15
MA21289A1 (fr) 1988-12-31
TNSN88049A1 (fr) 1990-07-10
AT395715B (de) 1993-02-25
NL8801315A (nl) 1988-12-16
FI882475A (fi) 1988-11-30
DK167532B1 (da) 1993-11-15
NO170086B (no) 1992-06-01
ATA140788A (de) 1992-07-15
IE881599L (en) 1988-11-29
FR2615735A1 (fr) 1988-12-02
OA08878A (fr) 1989-10-31
HK101790A (en) 1990-12-14
SE8801964L (sv) 1988-11-30
ES2009924A6 (es) 1989-10-16
FR2615735B1 (fr) 1991-01-11
DK291088A (da) 1988-11-30
KR960005152B1 (ko) 1996-04-22
KR880013928A (ko) 1988-12-22
IE61341B1 (en) 1994-11-02
BE1002146A3 (fr) 1990-07-31
DE3818106C2 (sv) 1993-07-01
ZA883731B (en) 1989-02-22
CA1317959C (en) 1993-05-18
FR2615854B1 (fr) 1990-12-28
IT1219698B (it) 1990-05-24
US5017588A (en) 1991-05-21
AR243885A1 (es) 1993-09-30
SE466449B (sv) 1992-02-17
LU87229A1 (fr) 1988-12-13

Similar Documents

Publication Publication Date Title
BG105925A (en) Novel tricyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
HUT56370A (en) Process for producing tricyclic carbapenem derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IL112622A (en) Iminoalkylamino or aminoalkylideneamino camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
UA6016A1 (uk) Спосіб одержання 4-епідауноміціна
ES8301961A1 (es) Procedimiento para la preparacion de nuevos benzo (b) tiofe-nos
ES2036926A1 (es) "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
ES8606282A1 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
HUT41713A (en) Process for production of //arol-cyclobutyl/ alkyl/-amins and medical preparatives containing thereof
NZ231380A (en) Xanthine derivatives and pharmaceutical compositions
ES8503686A1 (es) Procedimiento de preparar derivados de penicilina.
MY105538A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
MY103289A (en) New 5-(w-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes
MY102310A (en) New 5-oxy deravatives of tetrahydrofuran
HUT60275A (en) Process for producing 7-acyl-3-(substituted carbamoyloxy)-cef-3-em-4-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds
MY103731A (en) New 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes
UA41871C2 (uk) Похідні еритроміцину, спосіб їх одержання та фармацевтична композиція на їх основі
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
MY106235A (en) New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
MY101765A (en) Benzopyran derivatives, compositions containing them and processes for their production
EP0297621A3 (en) Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions containing them
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
FR2380272A1 (fr) Derives de la coumarine et d'indane-diode, utilisables comme medicament
MY105852A (en) New 2-methoxycarbonyl substituted n, n'' -di- (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.